Catalyst
Slingshot members are tracking this event:
AbbVie (ABBV) Reports Data Phase 3 Data Evaluating Veliparib in Non-Small Cell Lung Cancer and Triple Negative Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ABBV |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 19, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Veliparib, Non-small Cell Lung Cancer, Triple Negative Breast Cancer